Trump allegedly “enthusiastic” for oleandrin to be approved as a COVID-19 treatment
August 18, 2020Manufacturing and Production, Research and Development coronavirus vaccine, covid19
President Donald Trump reportedly wants to approve Phoenix Biotechnology’s oleandrin as a coronavirus treatment, despite a lack of evidence for …
China approves its first biosimilar of Roche’s Herceptin in HER2+ cancers
August 18, 2020Manufacturing and Production, Sales and Marketing China, Henlius, Herceptin, Roche, biosimilar
China’s National Medical Products Administration (NMPA) has given the green light to Shanghai’s Henlius for its biosimilar version of Roche’s …
NHS guidelines on prescription cannabis to be challenged in court
August 18, 2020Manufacturing and Production, Research and Development CBD, cannabis, epilepsy
The cannabis guidelines followed by the NHS are set to be challenged in court by the parents of a three-year-old …
China’s drug regulator says vaccines must have 50 percent efficacy to be approved
August 17, 2020Sales and Marketing COVID, China, coronavirus, vaccines
The Chinese Centre for Drug Evaluation (CCDE) has said that coronavirus vaccines must show 50 percent efficacy to be approved. …
Public Health England set to be replaced by a new agency to specifically deal with pandemics
August 17, 2020Sales and Marketing COVID, Public Health England, pandemic, phe
Public Health England is set to be replaced with a new agency to prepare the country to deal with future …
Amazon Pharmacy launches in India
August 17, 2020Sales and Marketing India, amazon, pharma
Amazon has entered the pharmaceutical market by launching ‘Amazon Pharmacy’ in India.
Sanofi to buy Principia Biopharma for $3.4 billion
August 17, 2020Sales and Marketing MS, Sanofi
Sanofi is set to buy California based Principia Biopharma in a deal that is worth $3.4 billion. This deal means …
FDA approves Roche’s Enspryng for neuromyelitis optica
August 17, 2020Sales and Marketing COVID, COVID-19, coronavirus
The FDA has granted approval for Roche’s Enspryng for treating the central nervous system disorder neuromyelitis optica. The drug (satralizumab) …
FDA panel votes 9-1 in favour of approval for Mesoblast’s Ryoncil in paediatric steroid-refractory acute graft versus host disease
August 14, 2020Medical Communications, Sales and Marketing FDA, Mesoblast, Ryoncil, pharma
It’s good news for Mesoblast as an expert FDA panel gave a glowing recommendation for the approval in the US …
Philippines expected to approve Russia’s ‘Sputnik’ COVID-19 vaccine
August 14, 2020Medical Communications COVID, COVID-19, coronavirus, vaccines
The Philippines is expected to begin large scale human testing of Russia’s controversial ‘Sputnik’ coronavirus vaccine. Rodrigo Duterte, the President …
Novavax and Janssen commit 90 million COVID-19 vaccine doses to UK Government with two new deals
August 14, 2020Manufacturing and Production, Medical Communications, Sales and Marketing COVID-19, J&J, JJ, Novavax, UK, pharma
The UK Government has signed a new deal with Johnson & Johnson and Novavax to secure 90 million orders of …
Top Russian doctor quits over questionable ethics that rushed through coronavirus vaccine approval
August 14, 2020Medical Communications
Professor Alexander Chuchalin has quit the Russian Health Ministry’s ethics council due to the quick approval process for the country’s …
Top Ten most popular articles on Pharmafile.com this week
August 14, 2020Medical Communications COVID-19, coronavirus, pandemic
The top 10 news stories this week once again focus on coronavirus treatments and vaccines, as President Putin announced that …
Gilead’s Truvada becomes first China-approved drug to prevent HIV-1
August 13, 2020Sales and Marketing China, Truvada, approval. HIV
China’s National Medical Products Administration (NMPA) has awarded approval to Gilead’s Truvada in a pre-exposure prophylaxis (PrEP) indication to prevent …
MHRA designates cenobamate as a Promising Innovative Medicine for treating drug resistant seizures
August 13, 2020Research and Development MHRA, cenobamate, seizures
Arvelle Therapeutics has announced that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has given their anti-seizure medication (cenobamate) …
COVID-19 patients are experiencing long-term effects from the virus
August 13, 2020COVID, COVID-19, coronavirus
Almost a third of doctors have treated patients for long-term symptoms caused by coronavirus, according to a new study.
FDA approves NS Pharma’s Viltepso for Duchenne muscular dystrophy, but concerns over benefit persist
August 13, 2020Sales and Marketing Duchenne Muscular Dystrophy, FDA, NS pharma, Viltepso
NS Pharma has claimed a tentative FDA approval for its Viltepso (viltolarsen) injection in the treatment of Duchenne muscular dystrophy …
Coronavirus fake news has led to hundreds of deaths, according to a new study
August 13, 2020Medical Communications COVID, coronavirus, fake news
At least 800 people have died around the world from COVID-19 misinformation in the first three months of 2020, according …
Racial minority groups are not adequately represented in COVID-19 clinical studies, research argues
August 12, 2020Research and Development COVID-19, Gilead, pharma, remdesivir
New research has warned that minority groups and people of colour are underrepresented in current trials for COVID-19 therapies, despite …
Bristol Myers Squibb announces positive results from Opdivo clinical trials
August 12, 2020Research and Development Bristol-Myers Squibb, Cancer, bristol myers squibb
Bristol Myers Squibb has announced positive data from two Phase 3 clinical trials of its drug Opdivo. The first trial …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
